Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
8.86 EUR | +0.68% | +1.84% | +1.03% |
May. 15 | Fine Foods confirms profit; Capex for period over EUR5 million | AN |
Apr. 30 | Emak best performer; Bialetti trailing. | AN |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- The company's profit outlook over the next few years is a strong asset.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The opinion of analysts covering the stock has improved over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company sustains low margins.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Food Processing
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+1.03% | 233M | A- | ||
+15.92% | 8.35B | D+ | ||
+3.37% | 7.62B | C- | ||
+1.49% | 6.01B | - | ||
-5.33% | 3.75B | B- | ||
-7.57% | 3.7B | D | ||
-2.94% | 1.34B | - | - | |
-26.08% | 1.13B | B+ | ||
+14.95% | 992M | - | ||
-9.40% | 925M | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- FF Stock
- Ratings Fine Foods & Pharmaceuticals N.T.M. S.p.A.